Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Murat Ozbalak"'
Autor:
Murat Özbalak
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S3- (2023)
Follicular lymphoma (FL) is the most common non-Hodgkin lymphoma in the United States and Europe1. The disease is potentially incurable and, treatment options comprise a wide spectrum from local radiotherapy to chemoimmunotherapy, based on the risk f
Externí odkaz:
https://doaj.org/article/215ec6ee156842e180c905acaf0027f8
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S40- (2023)
Objective: Amyloid deposits can be localized as a wall thickness or mass lesion either as AA amyloidosis or AL amyloidosis and may develop nearly on all organs. It is generally a mild, non–life-threatening entity with a good prognosis and rarely sh
Externí odkaz:
https://doaj.org/article/d34667c4ef264074b0a5d43ecc4f61f1
Autor:
Murat Özbalak, Metban Mastanzade, Dilek Özden Özlük, Tarık Onur Tiryaki, Simge Erdem, Ezgi Pınar Özbalak, Tuğrul Elverdi, İpek Yçnal Hindilerden, Ali Yılmaz Altay, Gülçin Yeğen, Ahmet Emre Eşkazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoğlu Beşışık
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 4, Pp 254-261 (2022)
Objective: Redditux® (RED), as a biosimilar rituximab, was approved in Turkey for all indications of the original Mabthera® (MAB) in March 2018. The aim of our study was to evaluate the efficacy and safety of RED in de novo diffuse large B-cell lym
Externí odkaz:
https://doaj.org/article/2a9fff72faa5467abb4cb2fad80cdfb5
Publikováno v:
Case Reports in Pulmonology, Vol 2017 (2017)
Bronchus Associated Lymphoid Tissue Lymphoma (BALTOMA) is a rare subgroup of pulmonary non-Hodgkin’s lymphomas (NHLs) comprising less than 1% of all cases. It constitutes 3.6% of all extranodal lymphomas and only 0.5–1% of primary pulmonary malig
Externí odkaz:
https://doaj.org/article/e1f6c583a87e433585555fe35167280b
Autor:
Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, Muhit Ozcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Fergun Yilmaz, Derya Koyun, Nihan Alkis, Inci Alacacioglu, Mehmet Sonmez, Irfan Yavasoglu, Anil Tombak, Ozgur Mehtap, Fatih Kurnaz, Orhan Kemal Yuce, Volkan Karakus, Mehmet Turgut, Derya Deniz Kurekci, Mesut Ayer, Muzaffer Keklik, Deram Buyuktas, Murat Ozbalak, Burhan Ferhanoglu
Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion trial conducted in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497f4e81be510fd6626ab724fb52159
https://hdl.handle.net/11424/289907
https://hdl.handle.net/11424/289907
Autor:
Metin Yusuf Gelmez, Fatma Betul Oktelik, Suzan Cinar, Murat Ozbalak, Ozden Ozluk, Melih Aktan, Gunnur Deniz
Publikováno v:
Journal of Hematopathology. 15:117-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c843cbdb5030cc514f46612e50b722
https://doi.org/10.1007/s12308-022-00497-5
https://doi.org/10.1007/s12308-022-00497-5
Autor:
Ezgi Pınar Özbalak, Sevgi Kalayoglu Besisik, Tarık Onur Tiryaki, Ali Yilmaz Altay, Metban Mastanzade, Murat Ozbalak, Özden Özlük, Gulcin Yegen, Ipek Yonal-Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci
Publikováno v:
İstanbul Kanuni Sultan Süleyman Tıp Dergisi. 13:194-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc166e085df245c323d653a464fbd7fb
https://doi.org/10.4274/iksstd.2021.35761
https://doi.org/10.4274/iksstd.2021.35761
Autor:
Sevgi, Kalayoglu Besisik, Murat, Ozbalak, Yavuz Burak, Tor, Alpay, Medetalibeyoglu, Murat, Kose, Naci, Senkal, Atahan, Cagatay, Mustafa, Erelel, Ahmet, Gul, Figen, Esen, Serap, Simsek Yavuz, Haluk, Eraksoy, Tufan, Tukek
Publikováno v:
Am J Blood Res
Objective: Severe acute respiratory syndrome (SARS) coronavirus 2 (SaRS-Cov-2) associated respiratory disease (COVID-19), announced as a pandemic, is a multisystem syndrome. SARS-CoV-2 directly infects and damages vascular endothelial cells, which le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::057b19bbc2f2f6cbbda3ff4b87ae43ae
https://pubmed.ncbi.nlm.nih.gov/35603126
https://pubmed.ncbi.nlm.nih.gov/35603126
Autor:
Teoman Soysal, Semra Paydas, Nuri Karadurmus, Elif Birtas, Murat Ozbalak, Hakan Goker, Birol Yildiz, Vildan Ozkocaman, Muhit Ozcan, Pervin Topcuoglu, Ayse Salihoglu, Burhan Ferhanoglu, Evren Ozdemir, Münci Yağcı, Leylagül Kaynar, Ihsan Karadogan
Publikováno v:
Annals of Hematology. 99:301-307
Classical Hodgkin lymphoma (cHL) is considered a curable disease; however, approximately one-third of responders experience disease relapse following first-line therapy. Several studies have shown the efficacy of brentuximab vedotin (BV) in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6aea850b32809621c52214b62a20362
https://doi.org/10.1007/s00277-019-03899-1
https://doi.org/10.1007/s00277-019-03899-1
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S33-(2021)
Objective Asparaginase has a very important role in ALL treatment among increasing of remission rate and duration. Multiple side effects prevent its regulatory use. Asparaginase reduce antithrombin 3, heparin cofactor II, protein C and plasminogen sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e79f030157e7c2ee76d22504dd376a8
http://www.sciencedirect.com/science/article/pii/S2531137921011585
http://www.sciencedirect.com/science/article/pii/S2531137921011585